Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Call Transcript 2022

Feb 9, 2022

61700_rns_2022-02-09_1eb11293-1701-4dbe-beff-2062384cf2fe.pdf

Call Transcript

Open in viewer

Opens in your device viewer

THRU ONLINE FILING

February 9, 2022

BSE Ltd. Phiroze Jeejeebhoy Towers Dalai Street Mumbai 400 023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra -(East). Mumbai-400051. Scrip Code: IPCALAB

Dear Sirs,

In accordance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a Conference Call to discuss the Company's Q3FY22 earnings and business update will be held on Tuesday, 1S"1 February, 2022 at 15.30 hrs 1ST.

Please find enclosed herewith the conference call / invite details.

This is for your information / record.

Thanking you

Yours faithfully For Ipca Laboratories Limited

Harish P. Kamath ' ' Corporate Counsel & Company Secretary

Enel: a/a

Ipca Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 66474444 E: [email protected] CIN: L24239MH1949PLC007837

t-

INVITE FOR Q3FY22 EARNINGS CALL OF IPCA LABORATORIES LTD

TUESDAY. 15th FEBRUARY. 2022 AT 15.30 HRS 1ST

Mumbai, 9th February, 2022: Ipca Laboratories Limited (BSE: 524494, NSE:IPCALAB) will organize a conference call for investors and analysts on Tuesday, 15,h February, 2022 from 15.30 hrs to 16.30 hrs 1ST to discuss Q3FY22 earnings and business update. The conference call follows the announcement of the Company's Q3FY22 financial results on Monday, 14th February, 2022.

Ipca Laboratories Limited management will be represented by Mr. A K Jain - Joint Managing Director and Mr. Harish Kamath - Corporate Counsel & Company Secretary.

The call will be hosted by Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.).

Details of the conference' call are as under:

Dial-in numbers

Universal Access: +91 22 62801384 + 91 22 7115 8285

Diamond Passcode link: click here

https://services.choruscall.in/DiamondPassReqistration/reqister7confirmationNumber =5613626&linkSecuritvStrinq=17468642a0

International Dial-In

Hong Kong Singapore UK USA
18.00 (HKT) 18.00 (SGT) 11.00 (BST) 05.00 (EDT)
Toll +852 30186877 +65 31575746 +44 2034785524 +1 3233868721

Please diaNn at least 5-10 minutes priorto the conference schedule to ensure that you are connected to the call in time.

For further information please contact

Anusha Kawthankar Ipca Laboratories Limited

Tel:+91-22-6210 6051 [email protected]

Nitin Agarwal / Parth Dalia Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.) Tel: +91- 9820413251 / 9867224187 [email protected] / [email protected]

Ipca Laboratories Ltd.

www.ipca.com

125, KandivliIndustrial Estate,CTS No.328,Kandivli (West),Mumbai400067 (Maharashtra), India | T:+91 2262105000 F:+91 2262105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837